SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ -- On October 13, 2026, ACROBiosystems hosted ACRO Innovation Day x AI at The Hangar in South San Francisco, California, bringing together biotech founders, industry leaders and scientists to explore how experimental validation can advance AI-driven drug discovery and biologics development. Following opening remarks by Mike Chen, Founder, Chairman and CEO of ACROBiosystems, three presentations from ACROBiosystems and two panel discussions examined how to translate AI-generated designs into experimentally validated candidates. The event connected perspectives across the discovery workflow, highlighting the importance of reliable biological tools and usable experimental evidence in turning advances in AI into better-informed drug development decisions.
Continue Reading